Company Financials

Shanghai Henlius Biotech, Inc. Financials

Hong Kong dollar

business Shanghai Henlius Biotech, Inc. Company Profile

Main Stock Listing

HKEX: 2696

Market Capitalization HK$37.53 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 33.96
Forward PE 25.91
Price to Sales TTM HK$5.35
Price to Book MRQ HK$8.18
Enterprise to Revenue 5.81
Enterprise to EBITDA 28.16

Financial Reports as of Dec. 31, 2023

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2023-12-31
Profit Margin 14.22%
Operating Margin 15.52%
Return on Assets TTM 4.97%
Return on Equity TTM 27.54%

Income Statement

Revenue TTM HK$6,457,504,593
Revenue per Share TTM HK$10.67
Quarterly Revenue Growth 2.70%
Gross Profit TTM HK$4,892,956,341
EBITDA HK$1,491,030,629
Net Income to Common TTM HK$918,076,155
Diluted EPS TTM HK$1.68
Quarterly Earnings Growth YoY 1.00%

Balance Sheet

Total Cash MRQ HK$1,083,136,869
Total Cash per Share MRQ HK$1.79
Total Debt MRQ HK$
Total Debt to Equity MRQ 107.68
Current Ratio MRQ 0.68
Book Value per Share MRQ HK$6.97

Cash Flow

Operating Cash Flow TTM HK$1,961,899,190
Levered Free Cash Flow TTM HK$-625,950,145

2696 Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 543,494,853
Float Shares 84,160,178
Avg 10 Volume 555,440
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 56.61%
% Held by Institutions 35.08%

Stock Price Summary

Beta 0.65
Fifty Two Week Low HK$15.20
Fifty Two Week High HK$92.00
Fifty Two Week Change 59.64%
Day 50 MA HK$64.59
Day 200 MA HK$58.74

Dividends and Splits

Forward Annual Dividend Rate HK$
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate HK$0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date